Status:
UNKNOWN
Turkish Validation of The Drooling Impact Scale
Lead Sponsor:
Marmara University
Conditions:
Hypersalivation
Cerebral Palsy
Eligibility:
All Genders
4-16 years
Brief Summary
The aim of this study is to investigate the reliability and construct validity of the Turkish version of the Drooling Impact Scale in children with cerebral palsy
Detailed Description
Drooling is common among several neurologic disorders such as cerebral palsy, Parkinson's disease, amyotrophic lateral sclerosis, which are the main diseases that physiatrist are one of the leading ph...
Eligibility Criteria
Inclusion
- Patients with unilateral or bilateral cerebral palsy at between the ages of 4-16
- Spastic, dyskinetic or mixed type cerebral palsy
- GMFCS level 3,4,5
- Stable drooling within at least one month
Exclusion
- Active infection of salivary glands
- Upper respiratory tract infection at the time of testing
- History of anticholinergic drug intake in the past three weeks
- Occurance of any above between test and re-test assessment that may interfere with the results
Key Trial Info
Start Date :
November 25 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 30 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04132765
Start Date
November 25 2019
End Date
August 30 2020
Last Update
November 27 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Esra Giray
Istanbul, Turkey (Türkiye), 34899